Fibrosis rather than blood pressure determines cardiac BNP expression in mice

Regulatory Peptides

Volumn 116, Issue 1-3, 2003, Pages 95-100

  Walther, Thomas ^a,c   Klostermann, Katrin ^b   Heringer Walther, Silvia ^a   Schultheiss, Heinz Peter ^a   Tschöpe, Carsten ^a   Stepan, Holger ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Angiotensin; Blood pressure; Fibrosis; Gene expression; Natriuretic peptide

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FIBROSIS; GENOTYPE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; WILD TYPE;

ANIMALIA;

EID: 0242266552     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2003.07.003     Document Type: Article

References (29)

1. Ganguly A., Chiou S., West L.A., Davis J.S. Atrial natriuretic factor inhibits angiotensin-induced aldosterone secretion: not through cGMP or interference with phospholipase C. Biochem. Biophys. Res. Commun. 28:1989;148-154.
2. Maack T. Role of atrial natriuretic factor in volume control. Kidney Int. 49:1996;1732-1737.
3. Stein B.C., Levin R.I. Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am. Heart J. 135:1998;914-923.
4. Walther T., Stepan H., Faber R. Dual natriuretic response to volume load in the fetal circulation. Cardiovasc. Res. 49:2001;817-819.
5. Tanabe A., Naruse M., Wasada T., Naruse K., Yoshimoto T., Omori Y.et al. Effects of acute hyperinsulinemia on plasma atrial and brain natriuretic peptide concentrations. Eur. J. Endocrinol. 132:1995;693-698.
6. Sakata Y., Yamamoto K., Masuyama T., Mano T., Nishikawa N., Kuzuya T.et al. Ventricular production of natriuretic peptides and ventricular structural remodelling in hypertensive heart failure. J. Hypertens. 19:2001;1905-1912.
7. de Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H.et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N. Engl. J. Med. 345:2001;1057-1059.
8. Troughton R.W., Frampton C.M., Yandle T.G., Espiner E.A., Nicholls M.G., Richards A.M. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 355:2000;1126-1130.
9. Vervoort G., Hertenberg F., Wetzels J.F., Smits P. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers. J. Hypertens. 16:1998;245-250.
10. Marttila M., Vuolteenaho O., Ganten D., Nakao K., Ruskoaho H. Synthesis and secretion of natriuretic peptides in the hypertensive TGR(mREN-2)27 transgenic rat. Hypertension. 28:1996;995-1004.
11. Jensen K.T., Cartens J., Pedersen E.B. Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans. Am. J. Physiol. 274:1998;F63-F72.
12. Murdoch D.R., McDonagh T.A., Byrne J., Blue L., Farmer R., Morton J.J.et al. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic plasma concentration: randomized comparison if the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am. Heart J. 138:1999;1005-1006.
13. Bruneau B.G., Piazza L.A., de Bold A.J. BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria. Am. J. Physiol. 273:1997;2678-2686.
14. He Q., LaPointe M.C. Interleukin-1beta regulates the human brain natriuretic peptide promoter via Ca(2+)-dependent protein kinase pathways. Hypertension. 35:2000;292-296.
15. Ito M., Oliveirio M.I., Mannon P.J., Best C.F., Maeda N., Smithies O.et al. Regulation of blood pressure by the type 1A angiotensin II receptor gene. PNAS. 92:1995;3521-3525.
16. Ichiki T., Labosky P.A., Shiota C., Okuyama S., Imagawa Y., Fogo A.et al. Effects on blood pressure and exploratory behavior of mice lacking angiotensin II type-2 receptors. Nature. 377:1995;748-750.
17. Tanimoto K., Sugiyama F., Goto Y., Ishida J., Takimoto E., Yagami K.et al. Angiotensinogen-deficient mice with hypotension. J. Biol. Chem. 269:1994;31334-31337.
18. Kimura J., Mullins J.J., Bunnemann B., Metzger R., Hilgenfeldt U., Zimmermann F.et al. High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J. 11:1992;821-827.
19. Ogawa Y., Itoh H., Tamura N., Suga S., Yoshimasa T., Uehira M.et al. Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. J. Clin. Invest. 93:1994;1911-1921.
20. Stepan H., Leitner E., Walter K., Bader M., Schultheiss H.P., Faber R.et al. Gestational regulation of the gene expression of C-type natriuretic peptide in mouse reproductive and embryonic tissue. Regul. Pept. 102:2001;9-13.
21. Pauschinger M., Knopf D., Petschauer S., Doerner A., Poller W., Schwimmbeck P.L.et al. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation. 99:1999;2750-2756.
22. Hein L., Barsh G.S., Pratt R.E., Dzau V.J., Kobilka B.K. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. [published erratum appears in Nature 1996 Mar 28;380(6572):366] Nature. 377:1995;744-747.
23. Gross V., Walther T., Milia A.F., Walter K., Schneider W., Luft F.C. Left ventricular function in mice lacking the AT2 receptor. J. Hypertens. 19:2001;967-976.
24. Ferreira A.J., Santos R.A., Almeida A.P. Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion. Hypertension. 38:2001;665-668.
25. Wei C.M., Heublein D.M., Perella M.A.et al. Natriuretic peptide system in human heart failure. Circulation. 88:1993;1004-1009.
26. Tamura N., Ogawa Y., Chusho H., Nakamura K., Nakao K., Suda M.et al. Cardiac fibrosis in mice lacking brain natriuretic peptide. PNAS. 97:2000;4239-4244.
27. Ogawa Y., Tamura N., Chusho H., Nakao K. Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart. Can. J. Physiol. Pharmacol. 79:2001;723-729.
28. Kang N.L., Walther T., Tian X.L., Bohlender J., Fukamizu A., Ganten D.et al. Reduced hypertension-induced end-organ damage in mice lacking cardiac and renal angiotensinogen synthesis. J. Mol. Med. 80:2002;359-366.
29. Ichihara S., Senbonmatsu T., Price E., Ichiki T., Gaffney A. Inagami. Angiotensin II Type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation. 104:2001;346-351.